Alere meets conditions for Axis-Shield takeover

Alere ($ALR) has claimed victory in its hostile takeover bid for medical diagnostic kit maker Axis-Shield. However, it had not yet conducted due diligence on the company. "Alere did no due diligence on Axis-Shield," a spokeswoman for Jefferies explained. "The offer has just gone unconditional, so the transaction process will go through." Jeffries is Alere's adviser for the deal. Item

Suggested Articles

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.

The FDA has authorized its first COVID-19 antibody test for use in doctors' offices, urgent care centers and emergency rooms.

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.